DexCom, Inc.
DE ˙ DB ˙ US2521311074
62,20 € ↓ -0,20 (-0,32%)
2026-06-04
AKTIENPREIS
SecurityDE:DC4 / DexCom, Inc.
InstitutionAscent Group, LLC
Latest Disclosed Ownership12,447 shares
Latest Disclosed Value $ 781,672
Ascent Group, LLC reports 6.39% increase in ownership of DC4 / DexCom, Inc.

On May 15, 2026 - Ascent Group, LLC filed a 13F-HR form disclosing ownership of 12,447 shares of DexCom, Inc. (DE:DC4) valued at $674,503 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 11,699 shares of DexCom, Inc.. This represents a change in shares of 6.39% during the quarter. The current value of the position is $774,203 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F DEXCOM COM 252131107 12,447 748 6.39 782 0.64 0.0089
2026-01-20 2025-12-31 13F DEXCOM COM 252131107 11,699 491 4.38 776 2.92 0.0265
2025-10-20 2025-09-30 13F DEXCOM COM 252131107 11,208 944 9.20 754 -15.75 0.0267
2025-07-21 2025-06-30 13F DEXCOM COM 252131107 10,264 899 9.60 896 40.06 0.0349
2025-05-16 2025-03-31 13F DEXCOM COM 252131107 9,365 676 7.78 640 -5.33 0.0275
2025-02-21 2024-12-31 13F DEXCOM COM 252131107 8,689 739 9.30 676 26.88 0.0508
2024-11-14 2024-09-30 13F DEXCOM COM 252131107 7,950 583 7.91 533 -36.29 0.0404
2024-08-15 2024-06-30 13F DEXCOM COM 252131107 7,367 1,072 17.03 835 -4.35 0.0680
2024-05-15 2024-03-31 13F DEXCOM COM 252131107 6,295 222 3.66 873 21.42 0.0769
2024-02-14 2023-12-31 13F DEXCOM COM 252131107 6,073 1,047 20.83 719 54.96 0.0682
2023-11-14 2023-09-30 13F DEXCOM COM 252131107 5,026 71 1.43 464 -14.86 0.0513
2023-08-14 2023-06-30 13F DEXCOM COM 252131107 4,955 -1,474 -22.93 546 -26.94 0.0602
2023-05-10 2023-03-31 13F DEXCOM COM 252131107 6,429 1,530 31.23 747 34.66 0.0795
2023-02-17 2022-12-31 13F DEXCOM COM 252131107 4,899 121 2.53 555 -3.99 0.0653
2022-11-15 2022-09-30 13F DEXCOM COM 252131107 4,778 98 2.09 577 50.26 0.0702
2022-08-05 2022-06-30 13F DEXCOM COM 252131107 4,680 3,601 333.73 384 -30.43 0.0459
2022-05-10 2022-03-31 13F DEXCOM COM 252131107 1,079 146 15.65 552 40.10 0.0642
2022-03-01 2021-12-31 13F DEXCOM COM 252131107 933 933 394 0.0502
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.